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Abstract
Our study aimed to investigate the potential radioprotective effects of N-acetylcysteine (NAC)
by comparing its biochemical effects with those of WR-2721, as a representative of clinically used
radioprotectors, in preventing oxidative damage caused by gamma irradiation (single dose, 6Gy)
in normal rat tissue. The rats (n=40) were divided randomly and equally into 4 groups:Control
(C), Radiation (R), R+NAC (received irradiation and 1,000mg/kg NAC) and R&#xFF0B;WR-
2721 (received irradiation and 200mg/kg WR-2721) rats. Liver tissues and blood samples were
harvested and utilized for reduced glutathione (GSH), malondialdehyde (MDA) and myeloperox-
idase (MPO) detection. Serum and tissue GSH levels of R rats decreased compared to those of
other groups (p<0.01). Tissue MDA levels of R+NAC and R+WR-2721 rats decreased compared
to R rats (p<0.01;p<0.05, respectively). Tissue MPO activities of R+NAC and R+WR-2721 rats
were higher than those of R rats (p<0.001). Serum MPO levels of R+WR-2721 rats were lower
than those of C rats and R rats (p<0.01, p<0.001, respectively). In conclusion, the study suggests
that the radioprotective effect against radiation-induced oxidative damage of NAC may be similar
to that of WR-2721.
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Our study aimed to investigate the potential radioprotective eﬀects of N-acetylcysteine (NAC) by com-
paring its biochemical eﬀects with those of WRﾝ2721,  as a representative of clinically used radiopro-
tectors,  in preventing oxidative damage caused by gamma irradiation (single dose,  6Gy) in normal rat 
tissue.  The rats (n＝40) were divided randomly and equally into 4 groups: Control (C),  Radiation (R),  
R＋NAC (received irradiation and 1,000mg/kg NAC) and R＋WRﾝ2721 (received irradiation and 
200mg/kg WRﾝ2721) rats.  Liver tissues and blood samples were harvested and utilized for reduced 
glutathione (GSH),  malondialdehyde (MDA) and myeloperoxidase (MPO) detection.  Serum and tissue 
GSH levels of R rats decreased compared to those of other groups (p＜0.01).  Tissue MDA levels of R
＋NAC and R＋WRﾝ2721 rats decreased compared to R rats (p＜0.01; p＜0.05,  respectively).  Tissue 
MPO activities of R＋NAC and R＋WRﾝ2721 rats were higher than those of R rats (p＜0.001).  Serum 
MPO levels of R＋WRﾝ2721 rats were lower than those of C rats and R rats (p＜0.01,  p＜0.001,  
respectively).  In conclusion,  the study suggests that the radioprotective eﬀect against radiation-
induced oxidative damage of NAC may be similar to that of WRﾝ2721.
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xidative stress occurs when there is excessive 
free radical production and/or low antioxidant 
defense,  and results in chemical alterations of biomol-
ecules causing structural and functional modiﬁcations.  
Reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) are products of normal cellular metab-
olism [1].  Overproduction of ROS is a harmful pro-
cess that can be an important mediator of damage to 
cell structures,  including lipids,  membranes,  proteins,  
and DNA.  Most cell damage caused by ionizing radia-
tion is also mediated by ROS generated from the 
interaction between radiation and water molecules in 
cells [1,  2].
　 The antioxidant system includes enzymes and anti-
oxidants that prevent the commencement of oxidative 
damage and/or its propagation [1,  3,  4].  Essential 
antioxidants are either endogenous or exogenous.  
They are typically categorized as free radical scaven-
gers and protective antioxidants.
　 Since ROS and RNS are highly reactive,  the 
approach most often employed in the study of oxidative 
stress is assessing the presence and quantity of the 
oxidative biomarkers of lipids (e.g.  malondialdehyde),  
nitrosive biomarkers (e.g.  nitric oxide),  antioxidant 
biomarkers (e.g.  glutathione,  catalase),  and inﬂam-
matory biomarkers (e.g.  neutrophils/myeloperoxi-
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dase) [1,  4,  5].
　 Reduced glutathione (GSH) is a multifunctional 
intracellular non-enzymatic antioxidant.  GSH is highly 
abundant in the cytosol,  nuclei,  and mitochondria and 
is the major soluble antioxidant in these cell compart-
ments.  It is considered to be the major thiol-disul-
phide redox buﬀer of the cell [1,  6,  7].
　 Polyunsaturated fatty acids,  when exposed to 
ROS,  can also be oxidized to hydroperoxides that 
decompose to hydrocarbons and aldehydes such as 
malondialdehyde (MDA) in the presence of metals 
[8].  This lipid peroxidation can cause severe impair-
ment of membrane function through increasing mem-
brane permeability and membrane protein oxidation 
[9,  10].  The causative factors of the events facilitat-
ing an inﬂammatory cascade such as neutrophil activa-
tion and the subsequent release of myeloperoxidase 
(MPO) were also studied [11].
　 The use of antioxidants has aroused increasing 
interest since it has been observed that the protection 
of normal tissues may provide an increase in tumor 
control by allowing for an increase in the radiation 
dose [12].
　 Thiol supplementation to maintain tissue redox 
balance has been studied by various researchers.  
Studies on various thiol radioprotectants such as WR
ﾝ2721 (amifostine) have demonstrated successful pre-
vention of radiation-induced damage to the intestinal 
epithelial and stem cells [13].  Cysteine and glutathi-
one delivery compounds have been used to protect 
normal and stem cells from radiation and anti-tumor 
agents [12,  13].  N-acetylycysteine (NAC),  a muco-
lytic agent and the drug of choice in paracetamol 
intoxication,  indirectly replenishes GSH through 
deacetylation to cysteine and prevents oxidative dam-
age through the scavenging of ROS [14ﾝ16].
　 The aim of our study was to investigate the poten-
tial radioprotective eﬀects of NAC and to compare its 
eﬀect with that of WRﾝ2721 (amifostine),  represent-
ing a clinically used radioprotector,  in the prevention 
of oxidative damage caused by gamma-irradiation 
(single dose,  6Gy) in normal rat tissue after whole 
body irradiation.  To evaluate the grade of damage or 
protection,  we measured the levels of some biochemi-
cal parameters (GSH,  MDA,  and MPO) of radiation-
induced oxidative stress in serum and in the liver 
homogenate as a representative of normal tissues.
Materials and Methods
　 Eight-week-old Wistar-Albino female (Gaziantep 
University,  Faculty of Medicine,  Experimental 
Medicine Research Unit; 170±20g bw) rats were 
used.  The rats were randomly selected and housed in 
polycarbonate cages with free access to tap water and 
rat chow with a dark/light cycle of 12: 12h.  A 1ﾝ
week acclimatization period was used.  The tempera-
ture was 22±2℃ and the relative humidity was 50ﾝ
70ｵ.  All procedures in this study were performed in 
accordance with the guidelines of the National 
Institutes of Health for the care and use of laboratory 
animals and also were approved by the Institutional 
Animal Care and Use Committee at Gaziantep 
University Faculty of Medicine.
　 Experimental design. After the stabilization 
period,  the rats were divided randomly into 4 equal-
size groups (10 rats per group),  namely the Control 
(C),  irradiation (R),  irradiation＋NAC (R＋NAC) and 
irradiation＋WRﾝ2721 (R＋WRﾝ2721) groups.  C rats 
received neither radioprotector nor irradiation,  but 
2.2ml of saline was injected intraperitoneally (i.p.).  
All groups of rats in the study (R,  R＋NAC and R＋
WRﾝ2721) received whole-body gamma irradiation as 
a single dose of 6Gy (50ｵ lethal total body irradia-
tion dose for rats).  Besides the irradiation,  R rats 
received 2.2ml of saline (i.p.) while the R＋NAC and 
R＋WRﾝ2721 rats received 1,000mg/kg (i.p.) NAC 
(containing 300mg of N-acetylcysteine,  Asist ampul,  
Hüsnü Arsan laç,  stanbul) and 200mg/kg (i.p.) WRﾝ
2721 (containing 500mg of amifostine,  Ethyol ﬂacon,  
Er-Kim laç,  stanbul),  respectively.  Saline,  NAC 
and WRﾝ2721 injections in the study groups were 
performed 15 min before irradiation.  The drug doses 
were chosen according to previous studies since they 
were observed to have beneﬁcial eﬀects on preventing 
radiation-induced oxidative damage following irradia-
tion after treatment with NAC or WRﾝ2721 using a 
similar protocol [12,  17,  18].  A cobaltﾝ60 telether-
apy unit (Shandong Xinhua SCCﾝ8000F Zibo,  China) 
was used for all irradiations.  The dose rate was 
1.80Gy/min at a distance of 80cm.
　 The study was terminated by sacriﬁcing the rats 
under Ketalar (Eczacıbası,  Turkey) anesthesia 
(35mg/kg,  intramuscularly) 72h after irradiation.  At 
termination,  each animalʼs liver tissue,  which was 
used as the representative tissue in our study,  was 
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harvested.  In addition,  blood samples were taken by 
cardiac puncture and then centrifuged,  and the serum 
was separated.  Serum and liver tissues of each animal 
were stored at －80℃ until biochemical analysis.
　 Biochemical analyses.
　 1. Measurement of reduced glutathione    
　 The GSH concentrations of the serum and tissues 
were measured using the method described by Beutler 
et al.  [19].  Fifty-mg specimens of rat liver tissues 
were homogenized in 5ｵ of NaCl.  Three ml of the 
precipitating solution (1.67g of metaphosphoric acid,  
0.2g of EDTA and 30g of NaCl in 100ml of distilled 
water) was mixed with 2ml of homogenate.  The mix-
tures were centrifuged at 3,000×rpm for 5min.  Two 
ml of ﬁltrate was taken and added to another tube,  and 
then 8ml of the phosphate solution (0.3M disodium 
phosphate) and 1ml of Ellmanʼs Reagent (DTNB) were 
added.  A blank was prepared with 8ml of phosphate 
solution,  2ml of diluted precipitating solution (3 parts 
to 2 parts distilled water),  and 1ml of DTNB reagent.  
A standard solution of the glutathione was prepared 
(40mg/100ml).  The optical density was measured at 
412nm in the spectrophotometer.  Serum GSH values 
were expressed as micromol/l while the tissue values 
were expressed as mmol/mgr tp.
　 2. Measurement of malondialdehyde levels    
　 Fifty-mg liver tissue specimens were homogenized 
in 0.15mol/l of KCI for MDA determination.  After 
the homogenate had been centrifuged at 3,000×rpm,  
the MDA levels in 50ｻl of tissue homogenate and 
serum were determined by thiobarbituric acid (TBA) 
reaction according to Yagi K.  [20].  The principle of 
the method is based on measuring the absorbance of 
the pink color produced by the interaction of TBA 
with MDA at 530nm.  Serum and tissue MDA values 
were expressed as nmol/ml.
　 3. Measurement of myeloperoxidase activity    
　 Three-hundred-mg rat liver tissue samples were 
homogenized in 0.02M EDTA (pH4.7) in a Teﬂon 
Potter homogenizer.  Homogenates and serum were 
centrifuged at 20,000×g for 15min at ＋4C.  After a 
pellet was re-homogenized in 1.5ml of 0.5ｵ hexa-
decyl-tirimethyl-ammonium bromide (HETAB) pre-
pared in 0.05M KPO4 (pH6) buﬀer,  it was re-centri-
fuged at 20,000×g for 15min at ＋4C.  The 
determination of the supernatantʼs MPO activity is 
based on the fact that it reduces o-dianizidine.  
Reduced o-dianizidine was measured at 410nm by 
spectrophotometer [21].  Serum MPO values were 
expressed as U/ml while the tissue values were 
expressed as U/gr tp.
　 Statistical analyses. The descriptive values of 
data were represented as means±standard error of 
the mean (S.E.M.).  The one-way analysis of variance 
(ANOVA) test was used for the determination of sig-
niﬁcant diﬀerences in the levels of GSH,  MDA and 
MPO between groups followed by the Bonferroni 
post-hoc test.  A value of p＜0.05 was considered sig-
niﬁcant,  and in all calculations,  the SPSS (v 
11.5; Lead Technologies,  Inc.,  Chicago,  IL,  USA) 
program was used.
Results
　 GSH levels in serum and liver tissues of rats.
Serum and tissue GSH values are shown in Table 1.  
In R rats,  the serum and tissue GSH levels were 
signiﬁcantly decreased when compared to those of all 
other groups of rats after irradiation (p＜0.01).  The 
serum and tissue GSH levels of R＋NAC and R＋
WRﾝ2721 rats were higher than those of the R rats 
and were close to the level of the C rats,  indicating 
that NAC or WRﾝ2721 treatment may be useful for 
scavenging oxygen-derived free radicals,  but these 
diﬀerences were not signiﬁcant (p＞0.05).
　 MDA levels in serum and liver tissues of 
rats. Serum and tissue MDA values are shown in 
Table 1.  With regard to the serum MDA levels,  
there were no statistically signiﬁcant diﬀerences 
among any of the groups of rats (p＞0.05).  We found 
a signiﬁcant diﬀerence between the R and C rats with 
respect to the tissue MDA levels (p＜0.001) while R
＋NAC and R＋WRﾝ2721 rats were not signiﬁcantly 
diﬀerent from C rats (p＞0.05).  The tissue MDA 
levels of R＋NAC and R＋WRﾝ2721 rats were sig-
niﬁcantly decreased when compared to those of the R 
rats (p＜0.01; p＜0.05,  respectively).
　 MPO activity in serum and liver tissues of 
rats. Serum and tissue MPO values are shown in 
Table 1.  The tissue MPO activity of the R group was 
signiﬁcantly reduced when compared to that of the C 
group (p＜0.001).  After applications of NAC and WR
ﾝ2721,  there was a marked increase in MPO activity 
in both R＋NAC and R＋WRﾝ2721 groups when 
compared to the R group (p＜0.001).  The tissue MPO 
activities of the C and R＋NAC rats did not diﬀer 
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signiﬁcantly (p＞0.05) while those of R＋WRﾝ2721 
rats were signiﬁcantly reduced when compared to 
those of the C rats (p＜0.05).  On the other hand,  the 
serum MPO levels of R＋WRﾝ2721 rats were found 
to be decreased signiﬁcantly when compared to those 
of the C rats (p＜0.01),  while those of the R and R＋
NAC rats were not diﬀerent signiﬁcantly (p＞0.05).  
However,  the serum MPO levels of R＋WRﾝ2721 
rats were signiﬁcantly decreased in comparison to 
those of the R rats after irradiation (p＜0.001).
Discussion
　 Ionizing radiation interacts with living cells and 
produces diﬀerent cytotoxic eﬀects.  Many of the 
actions of ionizing radiation are mediated through the 
production of ROS [22].  Cumulative results involving 
animals exposed to either non-lethal or lethal doses of 
X-radiation show that the biological eﬀects of the ion-
izing agent are dependent on the radiation dose and 
post-irradiation time [23].
　 We particularly investigated whether GSH supple-
mentation or direct radical scavenging would provide 
the primary protective eﬀect against radiation-induced 
alteration in the liver homogenate as a representative 
of normal tissues and serum.  In our study,  we also 
measured the activity of MPO,  as a major neutrophil 
protein,  in rats exposed to 6Gy radiation and investi-
gated the protective eﬀect of NAC on the radiation-
induced alteration in polimorfonuclear leukocyte func-
tion in comparison with that of WRﾝ2721.
　 The results of the present study demonstrated that 
whole-body irradiation in rats causes tissue damage in 
the liver as demonstrated by increased lipid peroxida-
tion (MDA) and decreased GSH levels.  The adminis-
tration of NAC stimulated GSH and inhibited MDA in 
the liver,  which is a similar eﬀect to that observed for 
WRﾝ2721.  In irradiated animals,  a marked radiation-
induced decline in the MPO activity of liver tissue was 
found in comparison to the controls.  The applications 
of each of NAC and WRﾝ2721 signiﬁcantly improved 
the radiation-induced decrease.  The limitations of our 
study include the absence of sampling of diﬀerent tis-
sues,  single-dose irradiation,  single-dose drug treat-
ment and the absence of research in the eﬀects after 
diﬀerent lengths of time to observe the possible altera-
tion in the oxidative and anti-oxidative biomarkers.
　 Among the large number of tested compounds,  the 
most-examined ones were cysteamine derivatives,  i.e.,  
aminothiol radioprotectors (for example cysteine,  
cystamine,  WRﾝ2721,  and glutathione) [12,  24,  25].  
Many studies have shown the radioprotective activity 
of WRﾝ2721,  which has been seen on the jejunum,  
colon,  lung,  and bone marrow in preclinical and clini-
cal studies [25ﾝ27].  There are many aspects of WRﾝ
2721 that limit its use clinically,  such as its toxicity 
and its requirement to be present at the time of irra-
diation in order to be eﬀective [28].  To discover new 
drug molecules is an extremely slow and very expen-
sive process,  with a high rate of failure.  The strategy 
of identifying new uses for present drugs is more 
reasonable and proﬁtable.
　 The intracellular content of glutathione is respon-
sive to environmental factors and is a function of the 
406 Acta Med.  Okayama　Vol. 62, No. 6   Kilciksiz et al.














C 2.26±0.40 0.143±0.021 24.45±1.94 14.87±1.66 0.954±0.056 1.124±0.053 　
R 1.00±0.11a† 0.061±0.006a† 27.28±2.55 23.99±0.61a＊ 0.975±0.131 0.352±0.029a＊　
R＋NAC 1.53±0.22 0.115±0.019 26.28±1.50 15.59±1.03b† 0.662±0.064 0.995±0.076b＊　
R＋WRﾝ2721 1.36±0.11 0.097±0.013 25.70±2.05 17.85±1.74b‡ 0.427±0.072a†､b＊ 0.876±0.048a‡､b＊
Each group consists of 10 rats.  C: Control rats,  R: rats that received irradiation (single dose,  6Gy),  R＋NAC: rats that received irradia-
tion (single dose,  6Gy) and were treated with NAC,  R＋WRﾝ2721: rats that received irradiation (single dose,  6Gy) and were treated with 
WRﾝ2721.  All values are given as the mean ± standard error of the mean (S.E.M.).  Statistical analysis was performed using the ANOVA 
test followed by the Bonferroni post hoc test.  aCompared to C rats,  bCompared to R rats; ＊p＜0.001,  †p<0.01,  ‡p＜0.05.  None of the 
serum and tissue values of the R＋NAC and R＋WRﾝ2721 rats were diﬀerent signiﬁcantly (p＞0.05).  The cases where statistically signiﬁ-
cant diﬀerences were found are given in the Table.
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balance between use and synthesis.  Thus,  oxidative 
stress in vivo mainly translates into a deﬁciency of 
GSH and/or its precursor,  cysteine [6,  7,  24,  29].  
GSH deﬁciency may not contribute to the speciﬁc 
symptoms of the disease and is recognizable mainly by 
secondary symptoms such as oxidative damage,  
reduced immune function and an overall decrease in 
health [29].  Thus,  NAC,  being a cysteine prodrug,  
scavenges free oxygen radicals and supplies depleted 
body glutathione stores.  NAC is a well-tolerated drug 
with a wide toxic-therapeutic window.  It has been 
shown to be beneﬁcial when GSH deﬁciency occurs,  
for example under endotoxic and septic conditions [29
ﾝ35].  These previous studies suggest that NAC is 
considerably promising.  Besides having proven anti-
oxidant,  anti-inﬂammatory and cytoprotective eﬀects,  
NAC also ensures endothelial protection and enhances 
microvascular blood ﬂow [36].
　 The results of the present study,  being parallel 
with these previous reports,  suggests that NAC is a 
very potent agent for replenishing the tissue GSH,  
which has a major role in the antioxidant defense 
mechanisms against irradiation injury [17,  37ﾝ40].  
Recently,  Mansour et al.  reported that pretreatment 
with NAC resulted in a signiﬁcant increase in the 
levels of the antioxidant enzymes,  which was in accor-
dance with our results,  and DNA damage [18].  They 
suggested that pre-treatment with NAC oﬀers protec-
tion against gamma-radiation-induced cellular damage.  
Neal et al.  supported this observation.  The results of 
their study indicate that both isomers of NAC have 
some,  although limited,  radioprotective eﬀect on the 
lung,  spleen,  liver,  and red blood cells of mice [37].  
In our rat model,  the results obtained were slightly 
diﬀerent from their results,  and in contrast to the 
signiﬁcant decrease in group R,  the tissue and serum 
GSH levels in the group with NAC supplementation 
with irradiation were maintained close to those of the 
control group.  In addition,  MDA levels decreased in 
our model and approached the control values in the 
liver,  but not in the serum.  Also,  the eﬀect of NAC 
was similar to the eﬀect observed for WRﾝ2721,  
which was in accordance with the results of other 
previous and recent experimental studies involving 
animal models and clinical trials,  which provided 
encouraging results [13,  15,  25ﾝ29,  37,  39].
　 Lipid peroxidation can cause severe impairment of 
membrane function by increasing membrane permeabil-
ity and membrane protein oxidation [1,  8,  9,  41].  It 
is suggested that NAC may protect cell membranes 
against lipid peroxidation and protein oxidation and 
helps maintain the integrity of cellular organelles [18,  
37,  39].  Our study indicated that the administration 
of NAC stimulates GSH and inhibits MDA to an 
extent similar to that observed for WRﾝ2721.  In a 
recent study on aged mice,  there were signiﬁcant 
decreases in lipid peroxide and protein carbonyl levels 
in the synaptic mitochondria of NAC-supplemented 
mice [42].
　 MPO is an essential enzyme for normal neutrophil 
function.  MPO is a heme enzyme that uses the super-
oxide and hydrogen peroxide generated by the neutro-
phil oxidative burst to produce hypochlorous acid and 
other reactive oxidants,  and when neutrophils are 
stimulated by various stimulants,  MPO increases like 
other cellular tissue-damaging substances [1,  24].  
Since Klebanoﬀ showed that the myeloperoxidase 
system is strongly bactericidal,  MPO has been con-
sidered to be an important component of the neutro-
philʼs antimicrobial defence mechanism [43].
　 The major dose-limiting sequelae following irradia-
tion are neutropenia and thrombocytopenia.  In previ-
ous studies,  it was reported that irradiation may 
result in leucopenia and bacteriemi and depressed 
phagocytosis [23,  44].  In our study,  in the liver tis-
sue,  the activity of MPO was decreased after irradia-
tion.  Konkabaeva et al.  showed that there are dose-
dependent changes; with increasing radiation dosage,  
the activity of neutrophilic MPO decreases [45].  In 
another study,  on day 1 after 7Gy irradiation,  MPO 
subcutaneously administered at 200ｻg/kg/d or 50
ｻg/kg/d,  twice daily,  was eﬀective on multilineage 
recovery in nonhuman primates after high-dose,  radi-
ation-induced myelosuppression [46].
　 In our study,  we investigated the eﬀect of NAC on 
radiation-mediated leucocyte function.  It was shown 
that the administration of NAC increased MPO activ-
ity in the liver tissue to levels approaching that of the 
control group.  With the application of WRﾝ2721,  
however,  there was a signiﬁcant increase in the MPO 
activity in comparison to the R group,  although this 
level was lower than that of the C group.  In serum 
MPO activity,  no intergroup diﬀerences were 
observed except for the diﬀerence in the R＋WRﾝ
2721 group.  In the earlier study with rats and rabbits 
exposed to either non-lethal or lethal doses of x-radia-
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tion,  it was shown that radiation depresses at least 2 
phases of phagocytosis,  namely,  the formation of 
leucocytes and their ability to migrate.  The maximum 
eﬀect on both phenomena occurred on the 3rd to 5th 
post-irradiation days.  The authors suggested that the 
decrease in leucocyte migration could not be attributed 
either to leucopenia or to plasma factors [23].
　 Studies have shown that NAC inhibits both the 
apoptotic process induced by reactive oxygen species 
and the imbalances of the redox potential.  This activ-
ity of NAC depends on the nucleophilic and antioxi-
dant properties of its thiol [47].  In a study on cystic 
ﬁbrosis,  it was reported that oral NAC was able to do 
both: GSH in blood neutrophils was signiﬁcantly 
augmented,  and airway neutrophil count and elastase 
activity were signiﬁcantly decreased [34].  However,  
it remains to be determined whether and how NAC 
inﬂuences basic cellular processes such as bacterial 
clearance,  neutrophil-endothelial cell interplay and 
apoptosis [36].  Since the participation of tissue 
neutrophils in the radiation-induced oxidative injury of 
diﬀerent tissues may occur at diﬀerent times,  time-
dependent and diﬀerent drug dose-dependent research 
may be required to observe the possible alteration in 
the oxidative and anti-oxidative parameters such as 
MPO [5,  23].
　 In conclusion,  considering the present results,  the 
prophylactic use of NAC seems to reduce the damage 
to the liver during radiotherapy.  The results of this 
study indicated that the administration of NAC stimu-
lates the anti-oxidant enzyme activities,  inhibits the 
lipid peroxidation,  and enhances the bactericidal 
activity of neutrophil by increasing induced MPO 
activity under radiation-induced oxidative stress.  
Although the ﬁndings of this study are limited to bio-
chemical parameters,  they give clues about the prob-
ability that the radioprotective eﬀect of NAC,  as 
shown in other studies,  may be similar to that of WR
ﾝ2721.  In spite of WRﾝ2721,  NAC,  as a drug that is 
safe and easy to use in clinical application,  has not yet 
been used clinically for this purpose.  Further experi-
mental studies are needed to prove this result and to 
rule out the potential protection of tumor cells.
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